{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:10:25Z","timestamp":1758820225566,"version":"3.37.0"},"reference-count":46,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T00:00:00Z","timestamp":1251331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Eur J of Neuroscience"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We investigated the effect of early vs. late initiation of levodopa treatment on dyskinetic movements, rotational behavior and molecular markers in hemiparkinsonian rats. Male Sprague\u2010Dawley rats received a unilateral 6\u2010hydroxydopamine (6\u2010OHDA) administration in the nigrostriatal pathway. Rats were divided into three groups treated with: (i) levodopa (6\u2003mg\/kg) twice daily for 22\u2003days starting at 4\u2003weeks after 6\u2010OHDA (Early group); (ii) levodopa at the same dose, regimen and duration but starting at 12\u2003weeks after 6\u2010OHDA (Late group), and (iii) saline starting at 4\u2003weeks after 6\u2010OHDA and continuing until the Late group finished treatment. Dyskinesias were quantified on days\u20031 and 22 of levodopa treatment. Striatal expression of preproenkephalin and preprodynorphin mRNAs, subthalamic cytochrome oxidase mRNA, and glutamate decarboxylase 67 mRNA in the pars reticulata of the substantia nigra was measured by<jats:italic>in\u2010situ<\/jats:italic>hybridization. After 22\u2003days of levodopa treatment, the percentage of rats showing dyskinesia was lower in the Early group than in the Late group (60% vs. 100%, respectively). No significant differences in total dyskinesia score were observed between both groups with the exception of the orolingual dyskinesias that were significantly less frequent in the Late group (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). No significant differences were observed in the molecular markers between the Early and Late groups. Prompt initiation of levodopa treatment might be able to delay some of the basal ganglia molecular and circuitry changes underlying the development of dyskinesia but, once developed, they are behaviorally and molecularly similar to those appearing after late initiation of levodopa.<\/jats:p>","DOI":"10.1111\/j.1460-9568.2009.06877.x","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T09:23:15Z","timestamp":1251364995000},"page":"823-832","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats"],"prefix":"10.1111","volume":"30","author":[{"given":"C.","family":"Marin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mengod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Obeso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.4.858"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.1999.0259"},{"key":"e_1_2_7_4_1","first-page":"1092","article-title":"Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson\u2019s disease","volume":"15","author":"Bezard E.","year":"2001","journal-title":"FASEB J."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870080202"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(85)91580-X"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.5.622"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1998.00285.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9202-3"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21918"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200002280-00015"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196702162760703"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410220105"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.5.529"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00633-2"},{"key":"e_1_2_7_16_1","first-page":"274","article-title":"Effects of bromocriptine and\/or L\u2010Dopa on neurons in substantia nigra of MPTP\u2010treated C57BL\/6 mice","volume":"29","author":"Fukuda T.","year":"1996","journal-title":"Brain Res."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66020501.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00765-9"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01167-5"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19990705)409:3<400::AID-CNE5>3.0.CO;2-4"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3565(25)32511-5","article-title":"The site of dopamine formation in rat striatum after L\u2010Dopa administration","volume":"217","author":"Hefti F.","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1998.6996"},{"key":"e_1_2_7_23_1","first-page":"1","article-title":"Biochemical pathophysiology of Parkinson\u2019s disease","volume":"45","author":"Hornykiewicz O.","year":"1987","journal-title":"Adv. Neurol."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.131045"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.5.676"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902890104"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0953-816x.2001.01843.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05848.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05265.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(20000915)37:4<298::AID-SYN7>3.0.CO;2-A"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.69041398.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430504"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb13642.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.62.1_suppl_1.S17"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.suppl_5.S1"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90796-X"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033447"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1994.1126"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5400.401"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120503"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71083-7"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440726"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02055.x"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20789"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10191"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e318065b09c"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120105"}],"container-title":["European Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1460-9568.2009.06877.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1460-9568.2009.06877.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:55:07Z","timestamp":1739310907000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1460-9568.2009.06877.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,28]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1460-9568.2009.06877.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1460-9568.2009.06877.x","archive":["Portico"],"relation":{},"ISSN":["0953-816X","1460-9568"],"issn-type":[{"type":"print","value":"0953-816X"},{"type":"electronic","value":"1460-9568"}],"subject":[],"published":{"date-parts":[[2009,8,28]]},"assertion":[{"value":"2009-08-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}